PATENT CLAIM ANALYSIS

Application Number: 15970954
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-02
Patent Classification: ["514", "210180"]

Abstract:
The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer.

Claim (Index 45):
The method of  claim 42  wherein the cancer is a sarcoma, lung cancer, gastrointestinal cancer, genitourinary tract cancer, liver cancer, bone cancer, nervous system cancer, gynecological cancer, or skin cancer.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 93.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15355995', '14620884', '15288605', '15497887', '14620903']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7754371067621152
- 35 USC 102 Novelty (BERT): 0.5465738093302784
- Combined Prediction Score: 0.7525507770189316
- Mean Citation Score: 392.308428
- Max Citation Score: 406.046
- Similarity Product: 211.574421479702

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test